An official who oversees a team at the Food and Drug Administration that reviews Neuralink Corp. devices was fired, according ...
The firings appeared to focus on employees in the agency’s centers for food, medical devices, and tobacco products. The Trump ...
The cuts hit the FDA's medical device center particularly hard, including reviewers and experts on AI-enabled medical ...
The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked ...
The FDA and its Center for Devices and Radiological Health (CDRH) were among several health-focused agencies caught in sweeping layoffs over the weekend as the Trump administration seeks | It’s ...
Reuters reports that roughly 20 people in the FDA’s office of neurological and physical medicine devices were let go over the ...
FDA Layoffs Shake Up Neuralink Trial Review Team. In a surprising move, the U.S. Food and Drug Administration (FDA) has laid off around 20 employees from its Office of Neurologica ...
The FDA let go of employees reviewing Neuralink's brain implant amidst widespread federal job cuts. While authorities claim no direct link to Neuralink, experts worry about the potential hindrance to ...
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
The total number of positions eliminated was not clear Sunday, but the firings appeared to focus on employees in the agency's ...
The U.S. FDA recently dismissed employees involved in reviewing Neuralink's brain-computer interface applications, raising concerns about potential delays in medical device processing. The layoffs are ...
including drug and medical device makers, which allows the agency to hire extra scientists to swiftly review products. Eliminating those positions will not reduce government spending. A former FDA ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果